Noxopharm (ASX:NOX) Total Stockholders Equity : A$6.58 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Total Stockholders Equity?

Noxopharm's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$6.58 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Noxopharm's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Noxopharm's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Noxopharm Total Stockholders Equity Historical Data

The historical data trend for Noxopharm's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Total Stockholders Equity Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Stockholders Equity

Get a 7-Day Free Trial

-0.10

12.87

40.78

24.12

9.07

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial										33.54	24.12	18.70	9.07	6.58

Noxopharm (ASX:NOX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Noxopharm's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6.575	-	0)	/	292.238
	=	0.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Noxopharm's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	6.575
	=	0.00

Noxopharm Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Noxopharm's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines